Protara Therapeutics outlines 2026 milestones for cancer trials

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. SPY
2. MDT
3. SPGI
4. USO
5. AAPL
6. DELL
7. NIO
8. ENOV
9. AON
10. A

Go back to Protara Therapeutics outlines 2026 milestones for cancer trials
(NASDAQ: TARA) Delayed: 3.90 +0.04 (1.04%)
Previous Close $3.86    52 Week High $ 
Open $3.81    52 Week Low $ 
Day High $3.92    P/E N/A 
Day Low $3.80    EPS $ 
Volume 222,412